This week’s health innovation funding included clinical research, diabetes care, women’s health, and more. — This week’s reported health innovation funding included: Paradigm, a New York, NY-based health tech startup focused on improving access to clinical research for patients, raised $203M co-led by ARCH Venture Partners and General Catalyst, with participation from F-Prime Capital, GV, LUX Capital, Mubadala Capital, Magnetic Ventures, and the American Cancer…

A doctor and an expert in hospital logistics have teamed up to create a new platform for automating and digitizing medication tracking in the hospital and during surgery. By eliminating handwritten labels on medications they’re reducing errors and improving life for nurses. — The Challenge It’s well known that healthcare lags behind many other industries when it comes to basic technology upgrades. Medical bills are often sent by mail, in paper form. Requests for patient records often arrive by fax. And nurses have to painstakingly label syringes by hand in order to track what medications…

The initiative aligns with StartUp Health’s recently-launched Health Equity Moonshot and commits the company to intentional and accountable action to reduce health inequities globally. — At StartUp Health we are committed to embedding equity and inclusion into all aspects of our work. We realize that this includes internal learning, infrastructure, and programming to develop our organizational capacity to operationalize diversity, equity, and inclusion (DEI) principles. As well, we realize that this requires supporting and investing…

This week’s global health innovation funding featured mental and behavioral health, nutrition, diabetes care, and fertility startups. — This week’s reported health innovation funding was highlighted by Genial Care, a São Paulo, Brazil-based startup that helps children with autism as well as their parents and caregivers. The $10M round is reportedly the first investment by General Catalyst in the behavioral health space in Brazil. <source>

In our year-end StartUp Health Insights report, we explore the factors that could make 2023 a break-out year for early-stage health startups (in spite of gloomy macro-ecomonic trends) and explain why a health moonshot mindset should always involve a long view of the market. — 2022 saw a dramatic decline in venture funding across the health innovation landscape compared to the year prior. While deal volume also dropped, the dip may signal an important opportunity to usher in a transformative phase of progress and create room for a new generation of health moonshot innovation —…

Watch five inspirational entrepreneurs from the StartUp Health portfolio who are transforming whole-person care for breast cancer patients and older adults, using new technologies to detect diseases and improve monitoring for children with scoliosis, and reimagining the patient experience for painful medical procedures. — On Dec 15, 2022, a select group of participants spent an hour meeting inspirational entrepreneurs from the StartUp Health portfolio who are working to achieve health moonshots that will improve the health and wellbeing of people around the world.

Founder Katharine Barnard, PhD, designed — and clinically validated — a new way for patients to communicate their needs to physicians. The result is an assessment tool that helps patients feel heard and doctors feel empowered to care. — Challenge Earlier this year in the New England Journal of Medicine, Surgeon General Vivek Murthy said this about the rise in burnout among healthcare workers: “Burnout is not only about long hours. It’s about the fundamental disconnect between health workers and the mission to serve that motivates them.”

Another busy week of health innovation funding saw money flowing into women’s health, respiratory care, genomics, food as medicine, and much more. — This week’s reported health innovation funding was topped by ShiftKey, a Dallas, TX-based startup helping healthcare facilities find licensed and certified professionals to fill available shifts. The company raised $300M led by Lorient Capital, with participation from Clearlake Capital and Health Velocity Capital. <source>

CEO & Co-founder Bechara Saab, PhD, spent years in the lab understanding how the brain works. With Mobio, he’s built a novel way to identify mental health challenges early and offer digital solutions that can scale globally. — Challenge Some problems seem too difficult. Suppose you were tasked with the job of finding 800 million psychiatrists who could deliver top-notch care for everyone suffering from mental illness around the globe. You’d just as well try to clear all the seashells from a beach. “Daunting” doesn’t begin to describe it.